Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,781 papers from all fields of science
Search
Sign In
Create Free Account
TMC 114
Known as:
114, TMC
, TMC-114
, TMC114
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
darunavir
darunavir ethanolate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Pharmacokinetic Interaction between Indinavir and Darunavir with Low-Dose Ritonavir in Healthy Volunteers
V. Sekar
,
E. Lefebvre
,
+4 authors
R. Hoetelmans
Intervirology
2010
Corpus ID: 24344819
Objective: To investigate the potential for a pharmacokinetic interaction between darunavir (DRV, TMC114, Prezista®), indinavir…
Expand
2007
2007
No patient left behind—better treatments for resistant HIV infection
B. Hirschel
,
T. Perneger
The Lancet
2007
Corpus ID: 19877006
2007
2007
Prediction of clinical benefits of ritonavir‐boosted TMC114 from treatment effects on CD4 counts and HIV RNA
A. Hill
,
J. Montaner
,
C. Smith
HIV Medicine
2007
Corpus ID: 35540882
The aim of the study was to predict reductions in progression to AIDS/death associated with the treatment benefit of…
Expand
2006
2006
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors
E. Poveda
,
F. Blanco
,
P. García-Gascó
,
Antonio Alcolea
,
V. Briz
,
V. Soriano
AIDS (London)
2006
Corpus ID: 24314666
Darunabir, formerly TMC114, is a new protease inhibitor (PI) under clinical development designed to be active against HIV strains…
Expand
Review
2006
Review
2006
Screening and selecting for optimized antiretroviral drugs: rising to the challenge of drug resistance
M. P. Béthune
,
K. Hertogs
Current Medical Research and Opinion
2006
Corpus ID: 11236605
ABSTRACT Background: Resistance to antiretroviral (ARV) drugs constitutes one of the greatest limitations to effective long-term…
Expand
2006
2006
Transport characteristics of the HIV protease inhibitor darunavir (TMC114) in Caco-2 monolayers
S. Lachau-Durand
,
P. Annaert
,
+4 authors
W. Meuldermans
2006
Corpus ID: 100095024
2006
2006
Prezista (darunavir, TMC-114) approved; may be important treatment advance.
J. James
AIDS treatment news
2006
Corpus ID: 30336792
A major new antiretroviral has been approved, for patients resistant to more than one protease inhibitor. There is no information…
Expand
Review
2005
Review
2005
New targets and new drugs in the treatment of HIV.
J. López-aldeguer
,
K. Aguirrebengoa
,
J. Arribas
,
J. Esté
,
J. M. Kindelán
Enfermedades Infecciosas y Microbiologia Clinica
2005
Corpus ID: 10699330
Review
2004
Review
2004
TMC-114 (Tibotec).
A. Shurtleff
Current opinion in investigational drugs
2004
Corpus ID: 37291376
Tibotec (formerly Tibotec-Virco) is developing TMC-114 as a potential treatment for HIV-1 infection. In February 2001, TMC-126…
Expand
2003
2003
Gateways to clinical trials. March 2003.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2003
Corpus ID: 470187
Gateways to clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE